Management Team

go cdse/zns quantum dots essay cialis mcclellanville essay topic my hometown viagra in the water artist gcse coursework pe cialis ne kadar kullanlmal nexium coupon 2016 see go ap literature essay question 33 steps to take when writing an academic essay drug seroquel addiction 13th amendment to the constitution abolishing slavery essay help me with english homework good research proposal example click here get link painted bird essays essay on noise pollution with pictures go to link see source link abilify halflife follow url compare contrast cultures essay go site
Craig Serio – Founder and Chief Executive Officer

Craig Serio is an experienced healthcare industry executive with expertise in healthcare technology.  He is the founder of several technology startups with successful exits. Each of these enterprises shared a common theme of greater efficiency and performance enhancement through innovative technology.

Mr. Serio co-founded RAIR technologies with Henry Goldberg, M.D. RAIR’s Managed Athletic Testing Services (MATS) division developed technology for detecting illegal substance abuse and the presence of banned substances in professional and amateur athletics. RAIR’s software utilized proprietary algorithms to reduce errors at the input stage and was deployed across several vertical markets including healthcare, sports, air and ground transportation and logistics. RAIR’s  work in developing large databases and parsing the pertinent data using algorithms to identify trends and produce reports was at the leading edge of technology at the time. RAIR was sold to LYTX.

Following RAIR Technologies Mr. Serio formed ClaimsBPO with two partners. Under their leadership the company grew from startup to 425 employees. ClaimsBPO developed systems to automate and streamline healthcare processes while reducing costs for both Payers and Providers.

ClaimsBPO was acquired by WNS, a portfolio company of Warburg Pincus, a  private equity firm headquartered in New York City. The ClaimsBPO team transitioned to form WNS Healthcare. Mr. Serio was appointed President and CEO.  Under Mr. Serio’s leadership the growth of the company continued to grow to 1800 FTE’s and a  post acquisition revenue increase of  7X and 9X increase in EBITDA. Mr. Serio was Chairman of WNS Healthcare and a member of the Board of Directors of WNS North America. WNS completed a successful IPO and is listed on the NYSE.

Mr. Serio was a managing director and entrepreneur in residence at The Resource Group (TRG), a private equity firm in Washington D.C. TRG Healthcare Inc. was launched as a healthcare investment venture with Mr. Serio as CEO and member of the Board of Directors. Additionally, he was CEO of Administrative Enterprises Inc. (AEI) in Glendale, Arizona and a member of AEI Board of Directors.

Mr. Serio was CEO of Capital Asset Advisors (CAA).  CAA provides guidance in raising capital and acquisition activity to companies developing innovative technology for the healthcare industry.

Mr. Serio studied for a BSBA. in Business Administration at Nova Southeastern University, H. Wayne Huizenga College of Business & Entrepreneurship. He is a member of the Medical Device Manufacturers Association (MDMA), Urgent Care Association (UCA), National Association of Chain Drug Stores (NACDS), American Society for Clinical Laboratory Science (ASCLS) and American Society for Microbiology (ASM).

Joseph V. DiTrolio, M.D. – Chief Medical Officer

Joseph V. DiTrolio, M.D. brings more than 35 years of experience in the practice of Urology to Thread Bioscience.

Dr. DiTrolio is on the faculty of New Jersey Medical School since 1985, where he holds a full professorship in the Department of Surgery, is a member of Alpha Omega Alpha Honor Society, and the Chairman of the Department of Urology at St. Barnabas Medical Center, Hackensack UMC/Mountainside Hospital and the former St. Mary’s Hospital in Orange, New Jersey.

He has been working with the East Orange Veterans Administration Since 1979 and continues to support and assist veterans.  His current position involves compensation and dispensation for nuclear, biological, and chemical warfare, as it relates to the urological system.

He personally holds numerous patents and has provided consulting services for medical device research and development efforts for some of the largest companies in the urological field.

Dr. DiTrolio was a pioneer in the early development of endoscopic medical devices. He worked for Vitreous State Laboratories in Washington, DC, under a NASA grant for the development and utilization of fiber optics. His groundbreaking work in fiber optic technology led to the developments on which all current endoscopic equipment is currently based.

He is a holder of both American and Italian passports and is a senior member of the European Urological Association, as well as the American Urological Association and American Board of Urology Diplomate. He has presented over one-hundred papers and published numerous domestic and international articles.

Dr. DiTrolio graduated from University of Richmond with a B.Sci. in Biology and attended the Universite’ de Paris, Sorbonne where he received an A. B. in French. He received his M.D from New Jersey Medical School and completed his Urology training at New Jersey Medical School. Since graduating medical school, he has been a member of the Alumni Association of New Jersey Medical School, where he served three terms as President and is currently the Chairman of the Board.

Everett Bellamy – General Counsel

Everett Bellamy is the former Senior Assistant Dean for the JD Program at Georgetown University Law Center. He served as a dean for 30 years. He has been an adjunct professor teaching a course on small business law and entrepreneurship.

He is a member of the American Bar Association, Business Law Section and the BusinessWeek Alliance Market Advisory Board. For twelve years, he was co-chair of the National Bar Association Law Professors Division. He taught a course in international business regulation at the European University Institute in Florence, Italy. He has advised small business owners and entrepreneurs for over twenty-five years.

Mr. Bellamy has been a guest lecturer at Howard University Small Business Development Center, Babson College (MA) School of Entrepreneurship and the University of Maryland’s Hinman CEOs Program in Entrepreneurship Education. He has been a founder and member of several startup companies, with a focus on technology, government relations and international business development.

In addition, he was an instructor in the Council on Legal Education Opportunity Program (CLEO). He taught in summer institutes held at Georgetown, the University of Richmond and the University of South Carolina Law Schools. He was a guest lecturer for the University of Maryland Thurgood Marshall Pre-Law Society. For the past two summers, he has been a guest lecturer in the Trials prelaw programs at Harvard Law School and NYU School of Law.

He received his B.S. and M.S. degrees from the University of Wisconsin, and is a graduate of the Cleveland-Marshall College of Law, Cleveland State University. He attended the Northwestern University School of Law, Searle Center on Law, Regulation and Economic Growth Program. 




Brian Feldman
Chief Innovation Officer 

Brian Feldman leads the engineering and development efforts at Thread Bioscience and has many years of practical engineering and design experience. He has worked on several medical device projects prior to joining Thread Bioscience. Mr. Feldman graduated from Penn State University (Schreyer Honors College) with a BS in Mechanical Engineering with distinction and honors. While there he was a member of the Future Truck Hybrid Electric Vehicle team and wrote an honors thesis about developing computer models for diesel engines.

Mr. Feldman has worked with many Fortune 500 companies, including General Electric, Goodyear, Progressive, Cummins, and Alcoa. Mr. Feldman holds US Patent (7,616,012) for innovations involving an advanced capacitance paddle developed while working for General Electric. His work with other companies has involved the development of computer programs and databases to aid in the analysis of data and automation of difficult tasks.

Mr. Feldman completed his Master’s Degree in Engineering and Technology Innovation Management at Carnegie Mellon University. While there he researched how knowledge was reused and transferred in innovative projects at companies.